RN7SL849P

Across TCGA pan-cancer cohorts, RN7SL849P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RN7SL849P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RN7SL849P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL849P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ACC, KIRC, and CESC are the cancer types where RN7SL849P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.667	<.001	135	view →
KIRC	OS	Tertile	All	0.742	0.821	.006	64	view →
CESC	OS	Tertile	IV	0.093	0.620	<.001	60	view →
KICH	DFS	Tertile	All	0.043	0.971	<.001	45	view →
PAAD	OS	Tertile	All	0.037	0.641	<.001	42	view →
UCS	DFS	Tertile	III,IV	0.134	0.440	.008	36	view →
BLCA	DFS	Tertile	III,IV	0.147	0.493	.013	27	view →
SKCM	OS	Tertile	IV	0.167	0.657	.003	21	view →
READ	OS	Tertile	All	0.262	0.714	.016	21	view →
ESCA	OS	Quartile	III,IV	0.766	0.475	.013	18	view →
LAML	DFS	Tertile	All	0.167	0.584	.002	18	view →
BRCA	DFS	Tertile	All	0.391	0.532	.031	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RN7SL849P–ACC (DFS)

Open the ACC breakdown →